CellCAN is proud to announce the 4th edition of its pan-Canadian Strategic Forum
This premier event convenes national and international leaders to address the pressing challenges and opportunities in biomanufacturing advanced therapies, including cell and gene therapies, mRNA vaccines, complex biologics and bio-printed tissue therapeutics.
Key themes for the 2026 Forum will include:
- Scaling Domestic Biomanufacturing Capacity: Strategies to enhance Canada's infrastructure for producing advanced therapies, ensuring readiness for future health needs.
- Bridging Talent Gaps: Addressing the critical need for skilled professionals in biomanufacturing, with insights.
- Fostering Industry-Academia Collaboration: Exploring models to strengthen partnerships between research institutions and industry to accelerate innovation and commercialization.
- Enhancing Regulatory Frameworks: Discussing approaches to streamline regulatory processes, facilitating efficient development and approval of advanced therapies.
- Integrating Digital Technologies: Examining the role of AI, digital twins and machine learning in optimizing biomanufacturing processes and ensuring quality control.